Even for killer T cells, which are specialised immune cells, searching for and eliminating cancer cells around the clock can be challenging. Scientists can produce stronger cancer-killing cells if they understand why killer T cells become exhausted.
In a new study, mice with immune systems that had been trained against the microbial protein flagellin did not experience the usual negative consequences of consuming food additive emulsifiers, pointing to a potential new strategy to battle many chronic inflammatory disorders.
Researchers created a unique implanted device that not only contains hundreds of thousands of insulin-producing islet cells but also has its own onboard oxygen factory that manufactures oxygen by splitting water vapour found in the body.
According to a study presented at the European Respiratory Society International Congress in Milan, Italy, babies and young children with better-developed populations of gut bacteria are less likely to develop allergy-related wheezing or asthma.
Young children who grow up in towns and cities experience higher respiratory illnesses than those who grow up in the country.
According to a study presented at the European Respiratory Society International Congress in Milan, Italy.
According to the findings of a multicenter phase II clinical trial, treating people who have differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, with the targeted tyrosine kinase inhibitor (TKI) cediranib in addition to their tre
Alzheimer's disease, a neurological disorder characterised with progressive cognitive decline, including memory loss, affects up to 5.8 million Americans today. Protein aggregates, made up of beta-amyloid or other proteins, occur in the brains of Alzheimer's patients. These beta-amyloid plaq
According to the findings of a multicenter phase II clinical trial, treating patients with differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, in addition to their treatment with the targeted tyrosine kinase inhibitor (TKI) cedir
A recent study from the University of Michigan Department of Neurosurgery and Rogel Cancer Centre demonstrates encouraging preliminary findings that a therapy combining cell-killing and immune-stimulating drugs is safe and effective in extending survival for patients with gliomas, a particu
When combating disease, our immune cells must reach their target as rapidly as possible. Immune cells actively build their own navigation system to traverse across diverse settings, according to researchers at the Institute of Science and Technology Austria (ISTA). This challenges earlier no